ClinVar Miner

Submissions for variant NM_014804.3(KIAA0753):c.943C>T (p.Gln315Ter) (rs762771340)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000760916 SCV000890812 pathogenic not provided 2018-12-24 criteria provided, single submitter clinical testing The Q315X variant in the KIAA0753 gene has been reported previously in the compound heterozygous state with another KIAA0753 variant in a fetus with short-rib thoracic dysplasia (Hammarsjo et al., 2017). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. unction either through protein truncation or nonsense-mediated mRNA decay. The Q315X variant is observed in 6/126332 (0.0047%) alleles from individuals of European (non-Finnish) background in large population cohorts, and no individuals were reported to be homozygous (Lek et al., 2016). We interpret Q315X as a pathogenic variant.
Rare Disease Group, Clinical Genetics,Karolinska Institutet RCV000590971 SCV000580666 pathogenic Jeune thoracic dystrophy; Joubert syndrome 2017-06-21 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.